101179-53-7

Basic information

• Product Name: Diniconazole
• Synonyms: E)-1-(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)-1-penten-3-ol; Nb (pesticide); Ortho spotless; Sumi 8-12.5WP; 1H-1,2,4-Triazole-1-ethanol, beta-((2,4-dichlorophenyl)methylene)-alpha-(1,1-dimethylethyl)-, (E)-; 1H-1,2,4-Triazole-1-ethanol, beta-((2,4-dichlorophenyl)methylene)-alpha-(1,1-dimethylethyl)-, (E)-(+-)-; 1H-1,2,4-Triazole-1-ethanol, beta-((2,4-dichlorophenyl)methylene)-alpha-(1,1-dimethylethyl)-, (betaE)-; (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol
• CAS NO: 101179-53-7
• Molecular Formula: C₁₅H₁₇Cl₂N₃O
• Molecular Weight: 326.221
• Mol File: 101179-53-7.mol
• Article Data: 20

Chemical Properties

• Melting Point: 148-149℃
• Boiling Point: 501.1°C at 760 mmHg
• Flash Point: 256.8°C
• Density: 1.27g/cm³
• Vapor Pressure: 7.35E-11mmHg at 25°C
• Refractive Index: 1.592
• Water Solubility: 4 mg/L at 25 ℃
• CAS DataBase Reference: Diniconazole(CAS DataBase Reference)
• NIST Chemistry Reference: Diniconazole(101179-53-7)
• EPA Substance Registry System: Diniconazole(101179-53-7)

Safety Data

• Hazard Codes: T:Toxic
• Hazardous Substances Data: 101179-53-7(Hazardous Substances Data)

Upstream product

• 69752-83-6 1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-one 
• 75-97-8 3,3-dimethyl-butan-2-one 
• 101179-53-7 1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)-4,4-dimethyl-pent-1-en-3-ol 
• 48115-38-4 norepinephrine 
• 76715-39-4 (E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-one 
• 53631-70-2 d,l-norephedrine hydrochloride 
• 60-29-7 diethyl ether 
• 6853-14-1 2-dimethylamino-1-phenylethanol 
• 2202-68-8 (S)-2-dimethylamino-1-phenylethanol 
• 103-69-5 N-ethyl-N-phenylamine 
• 76713-90-1 1-(4-chlorophenyl)-2-(1,2,4-triazol-1-yl)-4,4-dimethyl-pent-1-en-3-ol 
• 17605-71-9 2-dimethylamino-1-phenyl-propan-1-ol 
• 100-61-8 N-methylaniline 
• 552-79-4 (-)-N-methylephedrine 

Downstream Products

• 101179-53-7 (Z)-(R)-1-(2,4-Dichloro-phenyl)-4,4-dimethyl-2-[1,2,4]triazol-1-yl-pent-1-en-3-ol 
• 101179-53-7 (E)-(R)-1-(2,4-dichlorophenyl)-4,4-dimethyl 2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol 
• 101179-53-7 (S)-diniconazole 
• 101179-53-7 C₁₅H₁₇Cl₂N₃O 

Relevant articles and documents

Synthesis of optically active α,β-unsaturated triazolyl alcohols via asymmetric NaBH4 reduction of the corresponding ketones

Chiral ligands 5a-d were synthesized starting from L-proline and their application in the asymmetric NaBH4 reduction of α,β -unsaturated triazolyl ketones 2 was investigated. The corresponding α,β-unsaturated triazolyl alcohol derivatives (1a,

Preparation of a novel bridged bis(β-cyclodextrin) chiral stationary phase by thiol-ene click chemistry for enhanced enantioseparation in HPLC

A bridged bis(β-cyclodextrin) ligand was firstly synthesized via a thiol-ene click chemistry reaction between allyl-ureido-β-cyclodextrin and 4-4′-thiobisthiophenol, which was then bonded onto a 5 μm spherical silica gel to obtain a novel bridged bis(β-cyclodextrin) chiral stationary phase (HTCDP). The structures of HTCDP and the bridged bis(β-cyclodextrin) ligand were characterized by the 1H nuclear magnetic resonance (1H NMR), solid state 13C nuclear magnetic resonance (13C NMR) spectra spectrum, scanning electron microscope, elemental analysis, mass spectrometry, infrared spectrometry and thermogravimetric analysis. The performance of HTCDP in enantioseparation was systematically examined by separating 21 chiral compounds, including 8 flavanones, 8 triazole pesticides and 5 other common chiral drugs (benzoin, praziquantel, 1-1′-bi-2-naphthol, Tr?ger's base and bicalutamide) in the reversed-phase chromatographic mode. By optimizing the chromatographic conditions such as formic acid content, mobile phase composition, pH values and column temperature, 19 analytes were completely separated with high resolution (1.50-4.48), in which the enantiomeric resolution of silymarin, 4-hydroxyflavanone, 2-hydroxyflavanone and flavanone were up to 4.34, 4.48, 3.89 and 3.06 within 35 min, respectively. Compared to the native β-CD chiral stationary phase (CDCSP), HTCDP had superior enantiomer separation and chiral recognition abilities. For example, HTCDP completely separated 5 other common chiral drugs, 2 flavanones and 3 triazole pesticides that CDCSP failed to separate. Unlike CDCSP, which has a small cavity (0.65 nm), the two cavities in HTCDP joined by the aryl connector could synergistically accommodate relatively bulky chiral analytes. Thus, HTCDP may have a broader prospect in enantiomeric separation, analysis and detection. This journal is

Synthetic process of diniconazole

The invention discloses a synthetic process of diniconazole. The synthetic process of diniconazole includes steps of compounding pyrazolone hydrochloride by taking nitrogen triazole as raw materials; hydrolyzing pyrazolone hydrochloride and preparing pyrazolone; condensing pyrazolone to prepare ketene; water-washing and acidifying ketene to prepare ketene sulfate; hydrolyzing and reducing the ketene sulfate to obtain diniconazole. The synthetic process of diniconazole has the advantages of simple synthetic process, wide raw material source, low price, and high yield of the product diniconazole.